Portolani N - Search Results

1

Clinical and biological significance of miR-23b and miR-193a in human hepatocellular carcinoma.

Grossi I, Arici B, Portolani N, De Petro G, Salvi A. Grossi I, et al. Among authors: portolani n. Oncotarget. 2017 Jan 24;8(4):6955-6969. doi: 10.18632/oncotarget.14332. Oncotarget. 2017. PMID: 28036298 Free PMC article.

2

RT-PCR detection of fibronectin EDA+ and EDB+ mRNA isoforms: molecular markers for hepatocellular carcinoma.

Tavian D, De Petro G, Colombi M, Portolani N, Giulini SM, Gardella R, Barlati S. Tavian D, et al. Among authors: portolani n. Int J Cancer. 1994 Mar 15;56(6):820-5. doi: 10.1002/ijc.2910560611. Int J Cancer. 1994. PMID: 7509777

3

Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma.

De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S. De Petro G, et al. Among authors: portolani n. Cancer Res. 1998 May 15;58(10):2234-9. Cancer Res. 1998. PMID: 9605771

4

u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma.

Tavian D, De Petro G, Benetti A, Portolani N, Giulini SM, Barlati S. Tavian D, et al. Among authors: portolani n. Int J Cancer. 2000 Sep 1;87(5):644-9. Int J Cancer. 2000. PMID: 10925356

5

Androgen receptor mRNA under-expression in poorly differentiated human hepatocellular carcinoma.

Tavian D, De Petro G, Pitozzi A, Portolani N, Giulini SM, Barlati S. Tavian D, et al. Among authors: portolani n. Histol Histopathol. 2002 Oct;17(4):1113-9. doi: 10.14670/HH-17.1113. Histol Histopathol. 2002. PMID: 12371139

6

In vitro c-met inhibition by antisense RNA and plasmid-based RNAi down-modulates migration and invasion of hepatocellular carcinoma cells.

Salvi A, Arici B, Portolani N, Giulini SM, De Petro G, Barlati S. Salvi A, et al. Among authors: portolani n. Int J Oncol. 2007 Aug;31(2):451-60. Int J Oncol. 2007. PMID: 17611703

7

MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells.

Salvi A, Sabelli C, Moncini S, Venturin M, Arici B, Riva P, Portolani N, Giulini SM, De Petro G, Barlati S. Salvi A, et al. Among authors: portolani n. FEBS J. 2009 Jun;276(11):2966-82. doi: 10.1111/j.1742-4658.2009.07014.x. Epub 2009 Apr 16. FEBS J. 2009. PMID: 19490101 Free article.

8

Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression.

Petrelli A, Perra A, Schernhuber K, Cargnelutti M, Salvi A, Migliore C, Ghiso E, Benetti A, Barlati S, Ledda-Columbano GM, Portolani N, De Petro G, Columbano A, Giordano S. Petrelli A, et al. Among authors: portolani n. Oncogene. 2012 Oct 18;31(42):4517-26. doi: 10.1038/onc.2011.631. Epub 2012 Jan 16. Oncogene. 2012. PMID: 22249248 Free article.

9

Human hepatocellular carcinoma cell-specific miRNAs reveal the differential expression of miR-24 and miR-27a in cirrhotic/non-cirrhotic HCC.

Salvi A, Abeni E, Portolani N, Barlati S, De Petro G. Salvi A, et al. Among authors: portolani n. Int J Oncol. 2013 Feb;42(2):391-402. doi: 10.3892/ijo.2012.1716. Epub 2012 Nov 28. Int J Oncol. 2013. PMID: 23229173 Free PMC article.

10

Effects of miR-193a and sorafenib on hepatocellular carcinoma cells.

Salvi A, Conde I, Abeni E, Arici B, Grossi I, Specchia C, Portolani N, Barlati S, De Petro G. Salvi A, et al. Among authors: portolani n. Mol Cancer. 2013 Dec 13;12:162. doi: 10.1186/1476-4598-12-162. Mol Cancer. 2013. PMID: 24330766 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters